Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | DEFA14A: Others
Aileron Therapeutics | DEF 14A: Definitive information statements
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Aileron Therapeutics | NT 10-K: Others
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | 8-K: Current report
Aileron Therapeutics | DEFA14A: Others
Aileron Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data
No Data